Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0001610717-23-000176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-14 | TXG | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +1,865 | 4,610 | +68% | $0 |
| D | 2023-06-16 | 2023-06-14 | TXG | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +4,661 | 4,661 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-14 | A | A | 1,865 | $0.00 | 4,610 | D | — | — | (F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-14 | A | A | 4,661 | $0.00 | 4,661 | D | $57.62 · — to 2033-06-14 | 4,661 Class A Common Stock | (F2) 1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date. |